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Introduction
Adnexal masses are common in gynecology practice 
and the decision to treat the patient by observation, 
laparoscopy, or laparotomy will often depend upon 
basic evaluation in various age groups of women. In 
the United States, a woman has a 5-10% lifetime risk of 
undergoing surgery for an adnexal mass and, of these, 
benign neoplasms constitute a significant number, but 4% 
of new ovarian cancers expected to be diagnosed at local 
or regional states in 2007 (Jemal et al., 2007). Although 
most adnexal masses are benign, the goal of the diagnostic 
evaluation is to exclude ovarian cancer for which 5 year 
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Abstract
 Objective: To verify the basic preoperative evaluation in the discrimination between benign and malignant 
adnexal masses in our clinical practice. Materials and Methods: Data were collected on the records of 636 women 
with adnexal masses who had undergone surgery either by open or endoscopic approaches. Those with obvious 
signs of malignancy, any history of cancer, emergency surgeries without basic evaluation were excluded. The 
preoperative features by age, ultrasound and serum Ca125 level were compared with final histopathological 
diagnosis at the four departments of the institution. These are the general gynecology (Group 1: exploratory 
laparotomy), the gynecologic endoscopy (Group 2: laparoscopy and adnexectomy), the gynecological oncology 
(Group 3: staging laparotomy) and the gynecologic endocrinology and infertility (Group 4: laparoscopy and 
cystectomy). Results: There were simple and complex cyst rates of 22.3% and 77.2%, respectively. There were 
86.3% benign, 4.1% (n:20) borderline ovarian tumor (BOT) and 6.4% (n:48) malignant lesions. There were 3 
BOT and 9 ovarian cancers in Group 1 and one BOT and two ovarian cancer in the Group 2. During the surgery, 
15 BOT (75%) and 37 ovarian cancer (77%) were detected in the Group 3, only one BOT was encountered in the 
Group 4. The risk of rate of unsuspected borderline or focally invasive ovarian cancer significantly increased by 
age, size, complex morphology and Ca125 (95% CI, OR=2.72, OR=6.60, OR=6.66 and OR=4.69, respectively).
Conclusions: Basic preoperative evaluation by comprehensive ultrasound imaging combined with age and 
Ca125 level has proved highly accurate for prediction of unexpected malignancies. Neither novel markers nor 
new imaging techniques provide better information that allow clinicians to assess the feasibility of the planned 
surgery; consequently, the risk of inadvertent cyst rupture during laparoscopy may be significantly decreased 
in selected cases.  
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relative mortality rate approaches 50%. Management 
decisions often are influenced by imaging characteristic of 
the mass, serum Ca125 assay, the age and family history 
of the patient (Mancuso et al., 2004; Heilbrun et al., 2009; 
Shaaban et al., 2009).
The differential diagnosis of an adnexal mass includes 
both gynecologic and nongynecologic sources and, when 
arising from the ovary, may be a benign or malignant 
and or borderline tumor. Numerous studies have been 
looking at the risk of malignancy in adnexal masses, 
comparing imaging morphology and serology with 
either histopathology or mode of surgical management 
(Ghezzi et al., 2008; Yen et al., 2009; Arab et al., 2012; 
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Tantipalakorn et al., 2014).
Simple cysts, less than 10cm in diameter in the 
presence of a normal Ca125 levels are have a low risk 
of malignancy and the laparoscopic management of 
diameter with a low risk of malignancy index often can be 
managed conservatively in reproductive-age and even in 
postmenopausal women (RCOG 2003). Conversely, those 
that are more likely to be malignant are best managed with 
prompt surgery by a physician with advanced training and 
expertise in the management of ovarian cancer, such as a 
gynecologic oncologist. 
The differentiation between benign and malignant 
masses is, a clinical challenge in women with complex 
cysts who require surgical management; however, many 
can be managed laparoscopically. Conservative surgical 
procedures such as ovarian cystectomy is a method 
of choice in reproductive age women who desire to 
preserve their future fertility. Furthermore, laparoscopic 
diagnosis of suspicious cysts on clinical presentation 
prevents many laparotomies for the treatment of benign 
conditions in premenopausal women. Patient advantages 
as compared with laparotomy include superior cosmetic 
results, shorter recovery and at least equvalent results. 
However, one concern associated with laparoscopic 
cystectomy is inadvertent cyst rupture in an occult, early 
stage ovarian cancer with the presence of normal Ca125 
level in women who desire future fertility as well as a 
safe approach to their lesions. Intraoperative rupture of 
malignant cysts may cause dissemination of its content 
and may have some impact on survival. When malignancy 
is detected immediate surgical staging by laparoscopy or 
by converting laparotomy is indicated to prevent adverse 
outcomes in such cases (Gocmen et al., 2009).
The most appropriate surgical management of complex 
adnexal masses still controversial, depends on the clinical 
circumstances for women with varying risk of malignancy 
in the literature (Rangel et al., 2005).
Our aim was to investigate the relationship between 
preoperative features and modes of management in our 
series of adnexal mass and to review our institutional 
evaluation and management efforts on these lesions by 
patient’s age, ultrasonographic imaging and serologic 
means.
Materials and Methods
Six hundred and thirty six women who underwent 
surgical exploration for an adnexal mass at four referral 
departments of our institution were included for two years, 
from January 2008 to December 2009. Individual history 
of breast or ovarian cancer, cases with malignant ascites 
and with evidence of abdominal or distant metastasis or 
any emergency adnexal surgery without basic evaluation 
were excluded from the study.
The basic preoperative assessment to permit the 
distinction of benign from malignant were the patient 
history, pelvic examination, serum Ca125 levels and 
Transvaginal/Transabdominal ultrasound (TV-USG/TA-
USG) either with or without Doppler imaging studies was 
performed. Morphology of the masses was defined either 
as simple or as complex according to presence of papillary 
projections, septas, regularity of margins and ascites.
Modes of surgical management were determined 
regarding to the review of the preoperative imaging 
findings, Ca125 levels and age of patients and then they 
were admitted to the departments for the adjusted adnexal 
surgeries. For the initial clinical presentation, adnexal 
masses were categorized into one of four departments: 
General Gynecology (Group 1), Gynecological Endoscopy 
(Group 2), Gynecologic Oncology (Group 3), or 
Gynecologic Endocrinology and Infertility ( Group 4). 
Patients with large masses without high risk of malignancy 
and large masses or with high index of malignancy 
suspicion were operated in the General Gynecology 
(Group 1) and Gynecologic Oncology department (Group 
3) s via laparotomies, respectively. These categories, 
along with notation regarding the patient’s age and 
ultrasonographic features and serum Ca125 levels were 
helpful criterias in order to indicate whether the mass 
was likely to be benign or not. Typically benign, simple 
and small masses, were managed in the Gynecological 
Endoscopy (Group 2) and Gynecologic Endocrinology and 
Infertility department (Group 4) s via laparoscopic surgery.
During the laparoscopic surgeries, peritoneal washings 
were obtained and set aside before proceeding with 
insicion or resection of any suspicious adnexal mass in 
the each groups. The decision to perform cystectomy or 
oopherectomy dependent on the clinical circumstances 
such as future fertility, apperance of the mass during 
surgery, and the age of the women. The entire adnexa 
had removed once a malignant mass was diagnosed and 
the laparoscopic surgeons had requested intraoperative 
assistance with staging from a gynecologic oncologist 
immediately after frozen-section evaluation in all cases.
Preoperative findings and modes of management were 
compared with intraoperative findings, frozen section and 
final histopathological diagnosis in the four groups.
Statistical analysis
Data were collected and transferred into SPSS 
statistical database [SPSS Inc. Chicago, IL (Statistical 
Package for Social Science), Version 17 for Windows] 
on computer enviorenment. The Shapiro-Wilk test was 
used to assess the conformity of the continuous variables 
in the study to normal distribution. Continuous variables 
were expressed as mean, median, mini¬mum and 
maximum, whereas percentages and frequencies were 
used for categorical variables. Student’s t-test was used 
if it complied with the normal distribution and the Mann-
Whitney U-test was used if it did not comply. Intergroup 
differences for categorical values were assessed with chi 
square test. Logistic Regression test was performed to 
assess the risk of malignancy by the basic preoperative 
features of the study population. A P value lower than 0.05 
was accepted to be statistically significant.
Results
Mean age, gravida, maximum diameter of mass and 
Ca 125 levels of the study population were 39.1± 13.3 , 
2.4± 2.4, 80.6± 44.3mm, 67.4± 230.4 U/ml, respectively. 
Number of patients operated in the General Gynecology, 
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Gynecological Endoscopy, Gynecologic Oncology and 
Gynecologic Endocrinology and Infertility departments 
were 139(22%), 225(35%), 114(18%) and 158(25%), 
respectively. Total number of patients underwent 
laparoscopic surgery was 383 and 253 patients were 
operated by laparotomy. 
Preoperative patient characteristics and final 
histopathologic results are summarized in Table 1. There 
were simple and complex cyst rates of 22.3 % and 77.2 
%, respectively. Final histopathologic results revealed that 
the majority (89,3%) were benign, 3.1% of (n:20)  were 
borderline ovarian tumors (BOT) and 7.6% of (n:48) were 
malignant lesions.
The mean age, diameter of the mass, Ca 125 levels and 
the morphology of the mass were compared  in the  groups. 
The mean age was 43.7±12.1, 39.7±10.2, 49.1±14,1 and 
26.8±7.1 years in the groups, respectively.  The mean 
diameter of the mass was 109.7 ± 50.3, 59.3±22, 114±50 
and 60.5±24 mm, respectively The mean Ca125 level 
was 91±438.8, 39.3±74.7, 133.6±210,7 and 38.8±37 U/
ml, respectively. The variance of means of age, maximum 
diameter of mass and CA125 levels were found to be 
statistically significant (p=0.0003, p=0.0001, p=0.0007) 
that all values were higher in patients selected on the 
Gynecologic Oncology department. Comparisons of the 
morphology revealed a statistical difference between the 
women operated on the Gynecologic Endocrinology and 
Infertility and the Gynecological Endoscopy departments. 
Other group comparisons didn’t reach statistical 
significance (p>0.05). 
There were 3 BOTs and 9 ovarian cancers in the 
General Gynecology and one BOT and two ovarian 
cancers in the Gynecological Endoscopy. During the 
surgery, 15 BOTs (75 %) and 37 ovarian cancers ( 77%) 
were detected in the Gynecologic Oncology, only one 
BOT was encountered in the Gynecologic Endocrinology 
and Infertility, above mentioned rates of malignancy 
in the groups was statistically significant (P<0,05). 
Seventy-five (75%) of the malignant masses and ninety 
(90%) of the borderline masses operated via laparotomy, 
respectively. The rate of conversion to laparotomy for 
endoscopic suspicion of cancer was actually ~1%  for the 
whole endoscopic surgeries. Without any other diagnostic 
tool, only by basic evaluation, unexpected borderline or 
focally invasive ovarian cancer rate was 2.5 % in our 
study. Based on the basic preoperative evaluation in 636 
patients showed a sensitivity of 76.4%, and specificity of 
89% in differentiating benign and malign adnexal masses. 
Basic features of the study population; age (>40), 
tumor size (>10cm), morphology and Ca125 level (>35) 
were analysed by Logistic Regression and The Odd’s 
Ratios (OR) for malignancy risk were calculated as 
OR=2.72, OR=6,60, OR=6,66 and OR=4.69, 95% CI, 
respectively. The complex morphology gave the highest 
malignancy risk.
Although lower Ca125, younger age and smaller 
cyst size, it was noticed that  each mass with BOT  had a 
complex morphology wheras two masses with  mucinous 
cystadenocarcinoma had simple cyst morphology on the 
basic ultrasound imaging.
Discussion
Adnexal masses affects as many as 10% of female 
population, one to 0.1% of them were found to be with 
malignant neoplasms. Most clinicians have followed a 
policy of surgical treatment based on benign or malignant 
features of adnexal masses to recognize the potentials 
of laparoscopic approach for optimal management. 
The possibility of tumor spillage on invasive lesion is a 
major concern, especially with the laparoscopic surgery. 
Current basic evaluation for a pelvic mass palpaple on 
pelvic examination include a pelvic sonogram by either 
the abdominal or transvaginal approach and serum Ca125 
determination. Optional preoperative studies include other 
imaging techniques such as MRI, CT, PET studies and 
novel tumor markers. Whatever the preoperative work-
up, many unexpected, early stage ovarian cancers or 
borderline tumors have been reported in clinical practice.
Ovarian neoplasms are common in women of all ages 
and large screening series demonstrate that the majority 
of adnexal masses are benign. As many as %10 women 
in the United States will undergo surgery in their lifetime 
(Jemal et al., 2007). The laparoscopic management of 
adnexal masses appears a gold standard in most countries, 
but is still controversial in suspicious masses for in stage 1 
ovarian malignancy in which iatrogenic cyst rupture may 
be a significant prognostic factor. Accurate preoperative 
and intraoperative selection of the cases is mandatory, 
the diagnosis is usually based on histologic findings in 
surgical specimens of unexpected borderline or focally 
invasive ovarian cancers after tumor spill and malignant 
Table 1. Preoperative Characteristics and Final Pathological Results of Patients
 Gynecology (139) Endoscopy (225) Infertility (158) Oncology (114)  
Mean age (year) 43.7±12.1 39.7±10.2 26.8±7.1 49.1±14.1
Mean size (mm) 109.7±50.3 59.8±22 60.5±24 114± 50
Mean Ca125 level (U/ml) 91±438.8 39.3 ± 74.7 38.8 ± 37 133.6 ± 210.7
Mature Cystic Teratoma 17 (12.2%) 44 (19.6%) 19 (12%) 12 (10.5%)
Endometrioma 16 (11.5%) 58 (25.8%) 69 (43.7%) 9 (7.9%)
Mucinous Cystadenoma 25 (18%) 11 (4.9%) 6 (3.8%) 9 (7.9%)
Serous Cystadenoma 25 (18%) 47 (20.9%) 24 (15.2%) 8 (7%)
Borderline Ovarian Tumor 3 (2.2%) 1 (0.4%) 1 (0.6%) 15 (13.2%)
Ovarian Cancer 9 (6.5%) 2 (0.9%) 0 (0%) 37 (32.5%)
Other * 44 (31.6%) 62 (27.5%) 39 (24.7%) 21 (34.2%)
*Includes benign paraovarian masses, retroperitoneal masses, intraligamenter myoma, tuboovarian absess, hydrosalpinx, functional ovarian cysts, nongynecologic 
structures, etc.
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seeding have caused many gynecologic surgeons to avoid 
endoscopic surgery even in many benign cases. 
Today, new technologies such as ultrasonography 
and tumor marker assay have increased the diagnosis 
rate for adnexal masses. These combined diagnostic 
tools , however, frequently do not distinguish benign 
masses from early stages of an ovarian malignancy, 
which may result in suboptimal surgery (Mancuso et 
al, 2004). Murta and Nomelini reviewed that benign 
and early stage malignant lesions can present similar 
clinical characteristics and the clinicians can only rely 
on combination with color Doppler ultrasonography 
and /or tumor markers in relate to improve accuracy of 
these techniques to decide optimal management (Murta 
et al., 2006). The vast majority of adnexal masses can be 
safely managed laparoscopically provided that there are 
basic preoperative evaluation, expertise in gynecologic 
oncology and immediate access to frozen section 
diagnosis. On the other hand, accumulating scientific data 
support the laparoscopic approach to the large adnexal 
mass without any other signs of malignancy, as safe and 
effective treatment (Panici et al., 2007). 
Our data showed that the use of basic preoperative 
evaluation by age, Ca125 level and the size of the mass 
resulted in a prediction on 90% of borderline tumors and 
75% of ovarian cancers. The rate of unexpected borderline 
or focally invasive ovarian cancer which were evaluated 
by only the age, ultrasound imaging and serology was 
5.9% in our study.
The study of Riccardo et al. (2004) indicates that 
the rate of unexpected borderline or early stage ovarian 
cancer was 1.2% of 683 women under 40 years of age with 
adnexal masses. By contrast to Riccardo’s series, there is 
a higher incidence of unexpected borderline or focally 
invasive ovarian cancer, the rate was 5.9% in the present 
series in which both premenopausal and postmenopausal 
women either with simple or complex mass were included 
in our study.
Ultrasound evaluation of adnexal masses is the most 
widely used technique and sonographic findings of simple 
or complex mass, combined with serum Ca125 level and 
menopausal status provide an important information to 
determine the optimal surgery. It has also been suggested 
that colour-flow Doppler studies may be of benefit in 
assessing adnexal masses. However, several studies have 
reported that the addition of Doppler sonography resulted 
in a small improvement in positive predictive values at 
the cost of a significant decrease in sensitivity (Brown et 
al., 2007; Jokubkiene et al., 2007). Although, Doppler 
analysis in small percent of women were not included 
into the present study , it was noticed that malignant 
Doppler features were observed in both women with BOT 
and women with benign conditions. Exacoustos et al. 
concluded that neither complex cyst with the presence of 
papillae nor Doppler studies constituted highly sensitive 
preoperative markers for 33 women with BOT (Exacustos 
et al., 2005). The incidence of unexpected malignancies at 
laparoscopic surgery in the present study has been shown 
to be only ~1% ( 4 of 383 laparoscopies) that is lower than 
in the Marana et al series, in which frozen section revealed 
that the rate of BOT was 14.3% in 35 of 667 women with 
unexpected cystic vegetations (Marana et al., 2009).
Accumulating evidence supporting to the specialty 
care of a gynecologic oncologist on the basis of pelvic 
examination, imaging studies, family history as well as 
serum Ca125 determination (Gostout et al., 2006). As a 
single marker for prediction of ovarian cancer is Ca125 
level, in combination with ultrasonographic features, 
it is used to determine guidelines for the safe use of 
laparoscopy for adnexal masses. A survey by Robin et 
al for British Gynaecological Cancer Society (BGCS) 
reported that the incidence of malignant cases was 4.1% of 
women with adnexal mass on whom laparoscopic surgery 
had been performed (Robin et al., 2005). The serum 
glycoprotein Ca125 concentration is elevated in 80% of 
women with ovarian cancer; but reported sensitivities 
for early stage disease were found to decrease to 50% of 
women with Stage 1 ovarian cancer or with BOT’s. HE4 
(human epididymis protein 4) had the highest sensitivity 
at 72.9% in 259 women with adnexal masses, it seemed to 
be best single marker for Stage 1 disease, their results is 
promising for more accurate prediction of occult ovarian 
cancers (Moore et al., 2008). In addition to unpredictable 
levels in early stage ovarian carcinoma, it is well known 
that serum Ca125 values fluctuate during the menstrual 
cycle, but are rarely greater than 100 to 200U/mL in 
patients with benign conditions. Risk of malignancy in 
young females with adnexal masses was found as 14.6% 
of cases, slightly drops to 6-11% of premenopausal and 
up to 29-35% of postmenopausal women in the presence 
of high levels of Ca125 (Bristow et al., 2009).
Benign adnexal lesions affect young women, whereas 
malignant ovarian neoplasms occurs at more advanced 
ages. In the present study, laparoscopic management 
of complex adnexal mass appears to be safe in young 
women with moderately elevated Ca125 levels which were 
often associated with endometriosis and inflammatory 
processes. The incidence of managing an unexpected 
ovarian cancer by laparoscopy is 6.5 in 1000 women 
diagnosed with an adnexal mass, in which early stage 
ovarian carcinomas and tumors of malignant potential 
are neither often associated with high levels of Ca125 
nor older age. After the diagnosis of early stage ovarian 
cancer or BOT’s, to avoid tumor spillage and incomplete 
surgery, a converting laparotomy had to be performed 
in each case of the present study, to ensure an optimal 
approach. However, several studies have shown that these 
patients could benefit laparoscopic staging procedures 
by gynecologic oncologist experienced with advanced 
laparoscopy and is equivalent to traditional approach 
(Sagiv et al., 2005; Nezhat et al., 2009 ).
Several techniques have been proposed to differentiate 
benign and malign cases, especially using ultrasonographic 
morphological scoring (Arab et al., 2012; Yavuzcan et al., 
2013; Tantipalakorn et al., 2014). As a result of these 
studies; the sensitivity was reported from 68.5% to 
82.9% and the specificity 75.6% to 95.3% for prediction 
of malignancy. Similarly to the literature; in our study, 
the sensitivity and the specificity values were 76.4% and 
89% respectively. 
Combined with basic parameters (age, size of tumor, 
morphology and Ca125 level), current specific markers 
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and tools, such as, HE4 (22), proteomics (Vladimir et al., 
2008), FDG PET (Fenchei et al., 2002 ) and the ovarian 
crescent sign (Hillaby et al., 2004) in combination with 
clinical parameters for the detection of early stage ovarian 
cancer could provide improvements in mortality rates from 
late stage ovarian cancers.
Basic preoperative evaluation for the risk of malignancy 
is simple and fast and does not involve the use of any other 
complicated diagnostic tool, a comprehensive ultrasound 
imaging combined with age and Ca125 level has proved 
highly accurate for prediction of unexpected malignancies 
in our data.
Our study suggests that age (OR:2.72), size of the mass 
(OR:6.60) and serum Ca125 levels (OR:4.69), as well as 
complex morphology (OR:6.66) play essential roles in 
preoperative evaluation are enough to determine modes 
of surgery for adnexal masses.
The most appropriate surgical management would 
vary depending on preoperative evaluation in women 
with varying risk of malignancy and clinicians should 
decide the most appropriate place for them to be managed. 
The results of our study strongly suggest that the basic 
evaluation offers a valid, safe and discriminative tool for 
the most cases with adnexal mass.
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